We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Holiday Hand-Washing Quiz
Colds are circulating and it’s flu season. Time to test your knowledge about keeping hands clean.
Three Shots and a Booster for PI Patients
Even prior to the Omicron variant, U.S. experts urged four COVID-19 shots for this group after research found the vaccines pr…
PI Patients and COVID-19 Risk
In an update, immunologist says most PID patients appear no more at risk than the general population.
Plasma True Stories
A new video campaign asks real patients from around the world to look in the camera and explain why plasma donations matter.
Booster Shots for the Immune Compromised
U.S. agencies recommend a third COVID-19 vaccine for primary immunodeficiency patients and organ transplant recipients.
Sharing Best Practices in Immunology
CSL brought together 300 researchers and clinicians from more than 30 countries for a virtual conference.
Should PI Patients Stay Masked?
Loosening rules for COVID-19-vaccinated people don’t always apply to those who are immunocompromised, the Immune Deficiency F…
A 50-Year Wait
Sabine Pitschula knew she was sick, but it took decades to uncover the cause: primary immunodeficiency.
Do COVID-19 Vaccines Protect PI Patients?
U.S. launches a study to “fill the knowledge gap” about COVID-19 and immune deficiencies.
Video: What Is Primary Immunodeficiency?
Did you know? An estimated 6 million people worldwide live with serious immune system problems.
What Gives You Hope for the New Year?
After months of fear and uncertainty, we asked the rare disease community to share what drives them forward.
Showing Their Stripes, Virtually
With large events cancelled, primary immunodeficiency patients, aka “zebras,” Zoom to complete the annual walks for PI.
Popular search terms:
Americas
Asia Pacific
Europe
